Wintac’s promoter Veego Pharma, LLC has got approval from the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, to hold up to 100 per cent shares in the company.
Veego has now been accorded the approval of the DOP vide letter dated March 13, 2020, for 100 per cent FDI, thereby enabling Veego to hold up to 100 per cent shares in the Company.
Wintac received letter dated March 13, 2020 from Veego informing about the receipt of DoP approval and conveying its intention to continue with the delisting process. The promoter further confirms that acquisition of shares from the public shareholders shall be made in accordance with the SEBI Delisting Regulations and that Veego will make a public announcement for the same.
Wintac is a professionally managed and fully integrated pharmaceutical company that is committed in developing, manufacturing and marketing of high quality pharmaceutical formulations using innovative technologies and meeting the cGMP standards which are continuously updated to international requirements.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.70 |
| Dr. Reddys Lab | 1220.00 |
| Cipla | 1232.60 |
| Zydus Lifesciences | 928.05 |
| Lupin | 2305.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: